Cytokinetics incorporated ticker
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … WebCytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company...
Cytokinetics incorporated ticker
Did you know?
WebDec 30, 2024 · Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors.
WebWho is Cytokinetics Headquarters 350 Oyster Point Blvd, South San Francisco, California, 94080, United States Phone Number (650) 624-3000 Website www.cytokinetics.com Revenue $65M Stock Symbol CYTK Industry Pharmaceuticals Healthcare Cytokinetics's Social Media Is this data correct? View contact profiles from Cytokinetics Popular … WebDec 30, 2024 · Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. WebFeb 28, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential...
WebApr 6, 2024 · Cytokinetics Incorporated (NASDAQ: CYTK) stock closed at 36.42 per share at the end of the most recent trading day (a 0.72 % change compared to the prior day closing price) with a volume of 597.88K shares and market capitalization of 3.47B.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in …
WebAug 24, 2016 · Today's investors are interested in making a statement while earning a return. greenacres estate in beverly hillsWebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential … green acres ex-secretaryWebAnalysis of Cytokinetics Incorporated's forth quarter 2024 to forth quarter 2024 EBITDA Margin, ranking within Major Pharmaceutical Preparations industry and Healthcare Sector, EBITDA and Revenue quarterly change - CSIMarket greenacres facebookWebHeadquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, California, 94080 Website cytokinetics.com Telephone 1 650 6243000 No of Employees 253 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX flowering trees for sunWebMar 27, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the … green acres ex secretaryWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. A leader in muscle biology research with ... green acres estates west bath maineWebCytokinetics, Incorporated is a company in the U.S. stock market and it is a holding in 79 U.S.-traded ETFs. CYTK has around 18.7M shares in the U.S. ETF market. green acres estate beverly hills ca